- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource, 1 online resource.
- Language
-
Englisch
- Bibliographic citation
-
An Overview of Angiogenesis in Bladder Cancer ; volume:25 ; number:7 ; day:13 ; month:4 ; year:2023 ; pages:709-728 ; date:7.2023
Current oncology reports ; 25, Heft 7 (13.4.2023), 709-728, 7.2023
- Creator
-
Elayat, Ghada
Punev, Ivan
Selim, Abdel
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s11912-023-01421-5
- URN
-
urn:nbn:de:101:1-2023091908500065652478
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:57 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Elayat, Ghada
- Punev, Ivan
- Selim, Abdel
- SpringerLink (Online service)
Other Objects (12)
Role of tyrosine kinases in bladder cancer progression: an overview
Angiotensin II type 2 receptor promotes apoptosis and inhibits angiogenesis in bladder cancer
Leupaxin Promotes Bladder Cancer Proliferation, Metastasis, and Angiogenesis Through the PI3K/AKT Pathway
Angiogenesis in Cancer
Bladder cancer
Preliminary Study on Selected Markers of Oxidative Stress, Inflammation and Angiogenesis in Patients with Bladder Cancer
Treatment of bladder cancer
Inhibition of angiogenesis by leflunomide via targeting the soluble ephrin-A1/EphA2 system in bladder cancer
Whole-genome sequencing identifies ADGRG6 enhancer mutations and FRS2 duplications as angiogenesis-related drivers in bladder cancer
Platelets and cancer angiogenesis nexus
Association of interleukin-17A and chemokine/vascular endothelial growth factor-induced angiogenesis in newly diagnosed patients with bladder cancer
Selenium and risk of bladder cancer
Role of tyrosine kinases in bladder cancer progression: an overview
Angiotensin II type 2 receptor promotes apoptosis and inhibits angiogenesis in bladder cancer
Leupaxin Promotes Bladder Cancer Proliferation, Metastasis, and Angiogenesis Through the PI3K/AKT Pathway
Angiogenesis in Cancer
Bladder cancer
Preliminary Study on Selected Markers of Oxidative Stress, Inflammation and Angiogenesis in Patients with Bladder Cancer
Treatment of bladder cancer
Inhibition of angiogenesis by leflunomide via targeting the soluble ephrin-A1/EphA2 system in bladder cancer
Whole-genome sequencing identifies ADGRG6 enhancer mutations and FRS2 duplications as angiogenesis-related drivers in bladder cancer
Platelets and cancer angiogenesis nexus
Association of interleukin-17A and chemokine/vascular endothelial growth factor-induced angiogenesis in newly diagnosed patients with bladder cancer
Selenium and risk of bladder cancer
Role of tyrosine kinases in bladder cancer progression: an overview
Angiotensin II type 2 receptor promotes apoptosis and inhibits angiogenesis in bladder cancer
Leupaxin Promotes Bladder Cancer Proliferation, Metastasis, and Angiogenesis Through the PI3K/AKT Pathway
Angiogenesis in Cancer
Bladder cancer
Preliminary Study on Selected Markers of Oxidative Stress, Inflammation and Angiogenesis in Patients with Bladder Cancer
Treatment of bladder cancer
Inhibition of angiogenesis by leflunomide via targeting the soluble ephrin-A1/EphA2 system in bladder cancer
Whole-genome sequencing identifies ADGRG6 enhancer mutations and FRS2 duplications as angiogenesis-related drivers in bladder cancer
Platelets and cancer angiogenesis nexus
Association of interleukin-17A and chemokine/vascular endothelial growth factor-induced angiogenesis in newly diagnosed patients with bladder cancer